CeriBell, Inc. (CBLL)

Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis

BlackRock Inc. Acquires New Holdings in CeriBell, Inc. $CBLL

Bank of America Corp DE Has $5.86 Million Position in CeriBell, Inc. $CBLL

CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push

CeriBell, Inc. (CBLL) Q2 2026 Earnings Call Transcript

Here's What Key Metrics Tell Us About CeriBell, Inc. (CBLL) Q2 Earnings

CeriBell, Inc. (CBLL) Reports Q2 Loss, Tops Revenue Estimates

CeriBell Q2 Earnings Call Highlights

Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review

Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System

Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O'Keefe

Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference

Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026